NeuroSense Therapeutics OverviewNeuroSense Therapeutics Net Income
Profitability analysis for NRSN.
Quarterly Net Income
-$2.35M
↓ 174.74% YoY
As of Jun 2025
Annual Net Income (TTM)
-$8.66M
↓ 2.74% YoY
Trailing 12 months ending Jun 2025
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...